HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum activity of angiotensin converting enzyme and pulmonary radiography as prognostic criteria in sarcoidosis.

Abstract
To compare the prognostic value of the serum concentration of angiotensin converting enzyme (SACE) to that of pulmonary radiography, patients with mediastino-pulmonary sarcoidosis were followed over two years and then retrospectively placed in one of 2 groups, designated "cured" (CS) or "not cured" (NCS) on the basis of clinical and biologic criteria. The two groups were then compared with respect to the initial pulmonary radiologic image, and the initial SACE concentration. The initial SACE concentration (CS: 45.6 +/- 15.4 U . ml-1; NCS: 48.5 +/- 27.3 U . ml-1; means +/- SD) and the percentage of patients with elevated SACE (CS: 75%; NCS: 69%) did not differ significantly between the two groups; on the other hand, the percentage of patients with pulmonary nodules on their initial chest film was higher in the NCS group (50%) than in the CS group (21%; p less than 0.05). We conclude that pulmonary radiography is the more reliable prognostic criterion in mediastino-pulmonary sarcoidosis.
AuthorsD Choudat, G M Stanislas-Leguern, M S Mordelet-Dambrine, J Chretien, G J Huchon
JournalEuropean journal of respiratory diseases (Eur J Respir Dis) Vol. 64 Issue 5 Pg. 355-9 (Jul 1983) ISSN: 0106-4339 [Print] Denmark
PMID6309543 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Peptidyl-Dipeptidase A
Topics
  • Adult
  • Female
  • Humans
  • Lung Diseases (diagnostic imaging, enzymology)
  • Male
  • Mediastinal Diseases (diagnostic imaging, enzymology)
  • Peptidyl-Dipeptidase A (blood)
  • Prognosis
  • Radiography
  • Sarcoidosis (diagnostic imaging, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: